Angiogenesis is a well-established cancer hallmark and angiogenesis-related factors, among which the VEGF/VEGFR axis is the most extensively studied, therapeutically validated and characterized, are overexpressed in many cancers, including GEA, and correlate with a poor prognosis (12–14). The gene discussed is VEGFA; the disease is cancer.